Titan pharmaceuticals inc (TTNP)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Revenues:
License revenue

-

-

-

-

-

-

-

-

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total revenues

4,002

3,611

4,694

5,397

7,563

6,618

0

0

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating expenses:
Grant revenue

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

License revenue

-

-

-

-

-

-

-

-

-

-

-

-

15,105

-

15,030

15,004

760

1,671

2,584

3,495

3,646

3,646

3,644

4,931

6,218

9,057

8,146

5,948

0

-

0

0

-

-

-

-

-

0

-

Royalty revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,424

2,358

3,586

4,946

4,750

5,110

4,855

4,097

3,585

2,687

1,769

0

0

0

Grant revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

42

161

200

293

483

3,567

4,815

0

0

0

Total revenues

-

-

-

-

-

-

-

-

1,239

215

192

178

15,105

15,065

15,030

15,004

760

1,671

2,584

3,495

3,646

3,646

3,644

4,931

6,218

10,481

12,829

11,859

11,021

7,117

5,271

5,055

4,390

4,068

6,255

6,585

0

0

0

Cost of goods sold

1,155

1,288

1,028

1,018

842

538

0

0

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Research and development

7,675

7,242

7,225

7,516

7,466

7,478

7,930

8,734

9,378

9,648

9,431

8,307

7,552

6,126

5,171

4,591

3,944

4,675

5,136

4,908

4,557

4,075

3,408

4,305

5,346

8,309

9,953

11,269

11,453

10,610

9,328

8,563

10,537

11,206

12,959

12,785

0

0

0

Selling, general and administrative

11,957

11,925

11,693

10,184

8,333

6,866

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total operating expenses

20,787

20,455

19,046

17,523

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

General and administrative

-

-

-

-

-

-

-

-

-

-

5,143

4,799

4,816

-

4,512

4,252

3,791

3,755

3,210

3,285

3,245

3,046

3,100

2,880

2,868

3,063

3,567

3,810

4,235

4,877

4,637

4,486

4,308

3,368

3,171

3,444

0

0

0

Total operating expenses

-

-

-

-

-

-

-

-

14,711

14,717

14,574

13,106

12,368

10,722

9,683

8,843

7,735

8,430

8,346

8,193

7,802

7,121

6,508

7,185

8,214

11,372

13,520

15,079

15,688

15,487

13,965

13,049

14,845

14,574

16,130

16,229

0

0

0

Loss from operations

-16,785

-16,844

-16,316

-14,385

-10,142

-8,264

-8,372

-10,490

-13,472

-14,502

-14,382

-12,928

2,737

4,343

5,347

6,161

-6,975

-6,759

-5,762

-4,698

-4,156

-3,475

-2,864

-2,254

-1,996

-891

-691

-3,220

-4,667

-8,370

-8,694

-7,994

-10,455

-10,506

-9,875

-9,644

0

0

0

Other expense:
Interest expense, net

-943

-967

-969

-958

-935

-887

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,568

-1,336

-2,970

-4,867

-4,861

-8,286

-7,846

-7,062

-6,430

-3,362

-2,288

0

0

0

Non-cash gain on changes in fair value

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash loss on changes in the fair value of warrants

0

-

0

-

0

-

0

-

-

-

-

-1,543

-1,243

-825

157

154

1,229

4,512

3,696

2,233

1,332

-1,083

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other income (expense), net

-210

17

138

145

142

128

71

-45

-65

-55

-179

-55

-41

-70

-22

-26

-24

-8

0

-4

-8

-11

0

0

0

-

-

-

-

-183

0

0

0

-

-

-

0

-

-

Non-cash gain on debt extinguishment

-

-

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other income (expense), net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

0

0

-

0

-

Non-cash gain (loss) on changes in the fair value of warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

656

2,699

0

-

0

0

-

-

-

Other expense, net

-740

386

295

-878

-793

-759

-807

-835

-435

195

1,408

1,525

1,239

792

-179

-180

-1,253

-4,520

-3,696

-2,237

-1,340

1,072

725

-1,746

3,902

10,602

5,024

5,992

651

-6,810

-3,797

-2,595

-5,399

-4,697

-2,814

-4,087

0

0

0

Net loss and comprehensive loss

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss and comprehensive loss

-

-

-16,021

-15,263

-

-

-9,179

-11,325

-13,907

-14,307

-12,974

-11,403

3,976

5,135

5,655

5,994

0

-

0

0

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

0

0

0

Deemed dividend on trigger of down round provision

-

-

0

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss and comprehensive loss attributable to common stockholders

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss attributable to common stockholders

-

-

0

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss applicable to common stockholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-2,139

-4,000

1,906

9,711

0

0

0

-

-

-

-

-

-

-

-

-

-

Basic net loss per share

-

-

-0.18

-

-

-

-0.64

-

-

-3.55

-0.20

-0.16

-0.14

1.12

-0.12

0.58

-0.09

-0.12

-0.09

-0.11

-0.24

-0.15

0.04

-0.01

-0.02

0.52

-0.01

0.06

0.08

0.01

-0.12

-0.03

-0.09

-

-

-

-

-

-

Diluted net loss per share

-

-

-0.18

-

-

-

-0.68

-

-

-3.69

-0.20

-0.17

-0.16

0.86

-0.12

0.55

-0.09

-0.12

-0.09

-0.11

-0.24

-0.12

-0.05

-0.01

-0.02

0.46

0.00

0.00

0.07

-0.01

-0.07

-0.06

-0.09

-

-

-

-

-

-

Weighted average shares used in computing basic net loss per common share

-

-

-

-

-

-

-

-

-

-49,471

21,204

21,204

21,199

-47,939

21,199

20,508

20,060

20,061

20,060

20,060

20,031

-125,881

16,182

88,998

88,929

-183,619

82,544

82,527

78,256

74,826

66,839

64,984

59,387

-

-

-

-

-

-

Weighted average shares used in computing diluted net loss per common share

-

-

-

-

-

-

-

-

-

-49,632

21,204

21,204

21,376

-49,169

21,199

21,878

20,400

20,023

20,060

20,073

20,056

-125,936

16,249

88,998

88,929

-191,749

82,544

82,559

86,762

74,826

66,839

64,984

59,387

-

-

-

-

-

-

Net loss and comprehensive loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

Basic and diluted net loss per common share

-0.07

-

-

-0.38

-0.34

-

-

-0.25

-0.74

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.01

-0.12

-0.08

-0.01

-0.03

Weighted average shares used in computing basic and diluted net loss per common share

82,641

-

15,517

13,576

13,217

-

3,650

3,534

3,534

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Weighted average shares used in computing basic and diluted net loss per common share

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

59,386

59,276

59,248

59,248

59,248

License revenue
Total revenues

2

315

1,719

4,312

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Product revenue
Total revenues

899

1,006

1,055

940

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Grant revenue
Total revenues

3,101

2,290

1,270

513

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-